One of the most robust GWAS signals in Crohn’s disease is a missense mutation on the IL-23 receptor (IL23R) gene, which inspired the exploration of the above-mentioned treatments in Crohn’s disease [9]. This evidence concerns the gene IL23R and Crohn disease.